EdU (5-Ethynyl-2'-deoxyuridine)
Cat. # | Quantity | Price | Lead time | Buy this product |
---|---|---|---|---|
A0540 | 5 mg | – | in stock | |
10540 | 100 mg | $120 | in stock | |
20540 | 250 mg | $195 | in stock | |
30540 | 500 mg | $345 | in stock | |
40540 | 1 g | $590 | in stock | |
60540 | 5 g | please inquire | in stock |
EdU (5-ethynyl-2’-deoxyuridine) is a nucleoside, an analog of thymidine, carrying an ethynyl group. This nucleoside behaves as a substrate for cellular DNA replication machinery. After EdU incorporation, DNA containing ethynyl groups can be ligated by click chemistry reaction with various dye azides. Fluorescent DNA can be detected with microscopy, or cells can be sorted with FACS.
Recommended protocol
Calculator
Customers also purchased with this product
Cyanine5.5 azide
Far red / near infrared fluorescent Cyanine5.5 dye derivative for click chemistry.Cyanine3.5 NHS ester
Cyanine3.5 dye NHS ester derivative the labeling of amino-groups in biomolecules.
Add this product to your cart and
get free express delivery
get free express delivery
Vacuolin-1
Cell-permeable inhibitor of calcium-dependent lysosomal exocytosis.General properties
Appearance: | light beige to light brown solid |
Molecular weight: | 252.22 |
CAS number: | 61135-33-9 |
Molecular formula: | C11H12N2O5 |
Solubility: | in water, DMSO |
Quality control: | NMR 1H, HPLC-MS (95%) |
Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. |
MSDS: | Download |
Product specifications |
Product citations
- Kim, R.; Allbritton, N.L. A Microphysiological System with an Anaerobic Air‐Liquid Interface and Functional Mucus Layer for Coculture of Intestinal Bacteria and Primary Human Colonic Epithelium. Advanced Materials Interfaces, 2024, 11(25), 2400093. doi: 10.1002/admi.202400093
- Goedhart, J. Studentsourcing—Aggregating and reusing data from a practical cell biology course. PLOS Computational Biology, 2024, 20(2), e1011836. doi: 10.1371/journal.pcbi.1011836
- Dopeso, H.; Rodrigues, P.; Cartón-García, F.; Macaya, I.; Bilic, J.; Anguita, E.; Jing, L.; Brotons, B.; Vivancos, N.; Beà, L.; Sánchez-Martín, M.; Landolfi, S.; Hernandez-Losa, J.; Ramon y Cajal, S.; Nieto, R.; Vicario, M.; Farre, R.; Schwartz Jr, S.; van Ijzendoorn, S.C.D.; Kobayashi, K.; Martinez-Barriocanal, Á.; Arango, D. RhoA downregulation in the murine intestinal epithelium results in chronic Wnt activation and increased tumorigenesis. iScience, 2024, 27(4), 109400. doi: 10.1016/j.isci.2024.109400
- Alruwaili, M.M.; Zonneville, J.; Naranjo, M.N.; Serio, H.; Melendy, T.; Straubinger, R.M.; Gillard, B.; Foster, B.A.; Rajan, P.; Attwood, K.; Chatley, S.; Iyer, R.; Fountzilas, C.; Bakin, A.V. A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancers. Cell Reports Medicine, 2024, 5(3), 101434. doi: 10.1016/j.xcrm.2024.101434
Your item has been added.
View your
cart
or
proceed to checkout
The count of items is incorrect.